Article
Revisiting Type 2 Inflammation and Airway Hyper-responsiveness in COPD.
The journal of allergy and clinical immunology. In practice - 1 Jan 2026
Suter Philipp, Greig Robert, Chan Rory, Lipworth Brian J
Abstract excerpt
Airway hyper-responsiveness (AHR) is well established in asthma but remains under-recognized in chronic obstructive pulmonary disease (COPD). The recognition of COPD heterogeneity, particularly eosinophilic COPD and asthma COPD overlap, has increased interest in AHR as a clinical marker of type 2 (T2) inflammation. This phenotype is present in 20% to 40% of patients with COPD and has become a focus of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
